NCT00333060View on ClinicalTrials.gov

Study of OT-551 Eye Drops to Prevent or Delay Progression of Nuclear Cataracts Following Vitreous Removal

PHASE2TerminatedINTERVENTIONAL
Enrollment

164

Participants

Timeline

Start Date

November 30, 2005

Study Completion Date

January 31, 2008

Conditions
Epiretinal MembraneMacular Hole
Interventions
DRUG

OT-551 ophthalmic solution

Trial Locations (16)

Unknown

Peoria

Beverly Hills

Sacramento

Denver

Miami

Tallahassee

Chicago

Joliet

Baltimore

Cherry Hill

Forrest Hills

New York

Cleveland

Bala-Cynwyd

West Chester

Abilene

Sponsors
All Listed Sponsors
lead

Othera Pharmaceuticals

INDUSTRY